Market Overview

Medical bionics (artificial organs) products are implantable medical equipment and related devices used at hospitals, clinics, medical inspection centers, etc.
In the market of artificial organs except for extracorporeal circulation apparatuses, development of minimally invasive surgical techniques and launch of new devices are being invigorated. Although there are application criteria, transcutaneous surgical devices have been continuously adopted at clinical sites, which has increased the cases and products and has been affecting open surgery devices.
For chronic diseases, an increasing number of patients with osteoporosis drugs or antirheumatic drugs administered are also the factors of changes in the number of surgical cases, though partly.

FY2022 has seen continuous recovery since the previous fiscal year in the number of cases that use medical bionics that had been suppressed during the COVID-19 pandemic. Some cases have increased to or even exceeded the level before COVID.
On the other hand, however, shortage of product supplies has become serious, centered on products from overseas, stemming from delayed product delivery due to soaring costs for raw materials and transportation and from increased production costs. In such a status, the medical bionics (artificial organs) market (total 68 products, 34 categories) for FY2022 has been estimated as 668,784 million yen, a rise by 1.4% from the preceding fiscal year.

Noteworthy Topics

Trend of Six Brain Surgery Products

Of the market of medical bionics, the FY2022 market size for six brain surgery products decreased by 0.3% on a YoY to 10,391 million yen.
In the brain surgery area, because of increased cases of intravascular treatment, aneurysm clips for aneurysm surgery showed negative growth, while intravascular treatment devices including embolic coils were on the rise. The cases of using shunt valves or shunt systems for treatment of hydrocephalus, etc. increased slightly.
Because of an increase also in radiotherapy cases, craniotomy cases decreased, which led microplates and artificial bones used for brain surgery to continue being in the severe situations.

Future Outlook

The trends of medical bionics (artificial organs) by specialty area are as follows:
In the thoracic and cardiovascular surgery and cardiology areas, while recovery from COVID-19 impact is underway, the growth rate of artificial heart valves for TAVI (transcatheter aortic valve implantation) or TAVR (transcatheter aortic valve replacement) has slowed down. Artificial vessels are on a declining tendency, affected by DCB (drug coated balloons) in the abdominal and peripheral vascular area.
The number of orthopedic surgery cases is on the road to recovery from COVID-19 impact, with both markets of artificial joints and spinal fixation systems showing growth.
The artificial kidney and related products have slightly decreased from the previous fiscal year, in the situation where growth rate of the number of chronic dialysis patients is decreasing.
In such situations, the medical bionics (artificial organs) market for FY2023 is expected to rise by 2.3% on a YoY basis to 683,907 million yen and is projected to reach 707,014 million yen by FY2027.

Research Outline